Product
HS-20094
2 clinical trials
2 indications
Indication
Type 2 DiabetesIndication
ObesityClinical trial
A Multiple-dose, Randomized, Double-blind, Placebo and Positive Controlled Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-20094 in Subjects With Type 2 Diabetes.Status: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese SubjectsStatus: Recruiting, Estimated PCD: 2024-08-30